Clinical trial · people
Melanotan II: darker skin in 2 of 3 men in a small phase I trial
Checked against the paper Clinical trialPublished by PepVault
The takeaway
This early human trial found that 5 low Melanotan II doses darkened skin in 2 of 3 men, with mild nausea at most doses, spontaneous erections after dosing, and sleepiness and fatigue in one man at the top dose.
- Kind
- Clinical trial
- Studied in
- People
- Number studied
- 3
- Published
- 1996
- Journal
- Life Sci
What they tested
The team wanted to see whether Melanotan II is safe enough to give to people, what side effects it causes, and whether it darkens human skin.
How the study was done
A small, single-blind, placebo-controlled phase I trial in 3 healthy male volunteers. Over 2 weeks, they got shots under the skin on weekdays, switching each day between Melanotan II and saline (salt water), with the dose stepped up from a starting 0.01 mg/kg.

What they found
Two men reached 0.03 mg/kg and one reached 0.025 mg/kg. At 0.03 mg/kg, one of the two men had Grade II sleepiness and fatigue. Mild nausea that needed no anti-nausea medicine showed up at most dose levels. The men also had a pattern of stretching and yawning that seemed to line up with spontaneous erections, which came and went for 1-5 hours after a dose depending on the dose. One week after the last dose, 2 men had darker skin on the face, upper body and buttocks, judged both by eye and by a reflectance measurement. The team named 0.025 mg/kg/day as the single dose to use in later phase I studies.
What it doesn’t show
With only 3 men, no women and single blinding, this trial can't say how common these effects are or how strong the tanning is across people. It covered just 2 weeks of dosing, so it doesn't speak to longer-term safety.
The paper
Dorr et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996.
The compounds
More studies on Melanotan II
- Melanotan II: erections in 17 of 20 men with erectile dysfunctionClinical trial · people · 2000
- Melanotan II: erections in 8 of 10 men with psychogenic EDClinical trial · people · 1998
- Melanotan II: melanoma diagnosed in a 20-year-old woman after useObservational study · people · 2014
- Every study on Melanotan II
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.